Rapport Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Rapport Therapeutics Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Boston
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
RAPP
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002012593
EIN
88-0724208

Board of directors

Follow this board

Chief executives

Abraham Ceesay · Chief Executive Officer
Since June 2024

Director election results

Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 23 other boards. 23 are in the same sector.

Network of Rapport Therapeutics Inc.'s board connections Seaport Therapeutics Inc. Seaport Therapeutics I... Adial Pharmaceuticals Inc Adial Pharmaceuticals... Agios Pharmaceuticals Inc. Agios Pharmaceuticals... Alto Neuroscience Inc. Alto Neuroscience Inc. ArriVent BioPharma Inc. ArriVent BioPharma Inc... Beam Therapeutics Inc. Beam Therapeutics Inc. BioAge Labs Inc. BioAge Labs Inc. Bolt Biotherapeutics Inc. Bolt Biotherapeutics I... Charles River Laboratories International Inc. Charles River Laborato... City Therapeutics Inc. City Therapeutics Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Immunocore Holdings plc Immunocore Holdings pl... Kymera Therapeutics Inc. Kymera Therapeutics In... Maze Therapeutics Inc. Maze Therapeutics Inc. Natera Inc. Natera Inc. Nurix Therapeutics Inc. Nurix Therapeutics Inc... Abraham Ceesay Abraham Ceesay James Healy James Healy Jeffrey K. Tong Jeffrey K. Tong John Maraganore John Maraganore Paul M. Silva Paul M. Silva Ramiro Sanchez Ramiro Sanchez Robert J. Perez Robert J. Perez Steven M. Paul Steven M. Paul Wendy B. Young Wendy B. Young Rapport Therapeutics Inc.
Shared director Other board Same sector +7 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$22,023,904
11 purchases by 7 insiders
Sold, last 12 months
$47,221,733
72 sales by 6 insiders
Date Insider Transaction Shares Price Value
Oct 30, 2026 Third Rock Ventures V, L.P. Director, 10% owner Grant or award +238,095 $21.00 $4,999,995
Oct 30, 2026 Third Rock Ventures V, L.P. Director, 10% owner Grant or award +1,190,476 $21.00 $24,999,996
Oct 28, 2026 James Healy Director Open-market purchase +952,380 $21.00 $19,999,980
Oct 28, 2026 James Healy Director Open-market purchase +6,395 $21.00 $134,295
Oct 28, 2026 James Healy Director Open-market purchase +3,772 $21.00 $79,212
Oct 28, 2026 James Healy Director Open-market purchase +6,933 $21.00 $145,593
Oct 23, 2026 Ramiro Sanchez Director Open-market purchase +3,600 $27.35 $98,478
Oct 22, 2026 John Maraganore Director Open-market purchase +8,239 $26.38 $217,344
Oct 22, 2026 Steven M. Paul Director Open-market purchase +35,714 $27.28 $974,278
Oct 22, 2026 Wendy B. Young Director Open-market purchase +3,789 $26.39 $99,992
Oct 22, 2026 Paul M. Silva Director Open-market purchase +3,680 $27.08 $99,636
Oct 22, 2026 John Maraganore Director Open-market purchase +1,172 $26.92 $31,547
Oct 21, 2026 Troy A. Ignelzi Officer (Chief Financial Officer) Open-market purchase +5,500 $26.10 $143,550
Oct 21, 2026 Abraham Ceesay Director, Officer (Chief Executive Officer) Open-market sale −2,210 $29.16 $64,448
Oct 7, 2026 Abraham Ceesay Director, Officer (Chief Executive Officer) Open-market sale −1,147 $30.66 $35,167

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States

Questions about Rapport Therapeutics Inc.

Who is the CEO of Rapport Therapeutics Inc.?

Abraham Ceesay has been Rapport Therapeutics Inc.'s Chief Executive Officer since June 2024.

How many directors are on Rapport Therapeutics Inc.'s board?

Rapport Therapeutics Inc.'s board has 11 directors: Abraham Ceesay, James Healy, Jeffrey K. Tong, John Maraganore, Paul M. Silva, Ramiro Sanchez, Reid M. Huber, Robert J. Perez, Steven M. Paul, Terry-Ann Burrell and 1 other.

Are Rapport Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Rapport Therapeutics Inc. insiders bought $22.0 million of shares in 11 purchases and sold $47.2 million of shares in 72 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Rapport Therapeutics Inc. connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="rapport-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.